Showing 2761-2770 of 4012 results for "".
- Dr. Desai Reflects on AAD's Progress Over Past Yearhttps://reachmd.com/news/Dr-Desai-Reflects-AAD-Progress-Over-Past-Year/2471547/Seemal Desai, MD, FAAD, achieved his dream and propelled the profession forward during his year as American Academy of Dermatology (AAD) president, but work remains to be done, he said in his farewell address at the 2025 AAD Annual Meeting in Orlando, Florida. “This year as your president
- Revolutionizing Cardiac Care: New Technologies and Their Impacthttps://reachmd.com/news/revolutionizing-cardiac-care-new-technologies-and-their-impact/2471460/Recent advancements in cardiac rhythm management and the use of smartwatches for detecting congestive heart failure represent a significant leap forward in cardiac care, offering improved patient outcomes and more accessible diagnostic tools. T
- Synthetic Peptide S100A1ct: A Promising Therapeutic for Heart Failurehttps://reachmd.com/news/synthetic-peptide-s100a1ct-a-promising-therapeutic-for-heart-failure/2471397/Recent studies highlight the therapeutic potential of a synthetic peptide, S100A1ct, in enhancing cardiac function and survival in heart failure models, marking a significant step forward in cardiovascular medicine. Introduction to S100A1 Prote
- Skinbetter Science Launches BioRewind Skin Health Dietary Supplement to Combat Skin Glycationhttps://reachmd.com/news/skinbetter-science-launches-biorewind-skin-health-dietary-supplement-to-combat-skin-glycation/2473747/Skinbetter science launched BioRewind, a skin health dietary supplement with a purpose of visibly improving skin quality by helping reduce advanced glycation endproducts (AGEs), on Monday. Glycation is a key contributor to skin aging and this supplement’s formula is clinically demonstrate
- Link Between Simple Congenital Heart Diseases and Epilepsy Risk Revealedhttps://reachmd.com/news/link-between-simple-congenital-heart-diseases-and-epilepsy-risk-revealed/2471377/A recent study highlights the increased risk of epilepsy associated with simple congenital heart diseases, particularly patent foramen ovale (PFO). This finding could guide future treatment and prevention strategies in affected patients. The stu
- Unraveling Chromosomal Complexities: A New Genetic Diagnosis in Lennox-Gastaut Syndromehttps://reachmd.com/news/unraveling-chromosomal-complexities-a-new-genetic-diagnosis-in-lennox-gastaut-syndrome/2471355/A groundbreaking case study reveals the first-known chromothripsis involving chromosomes 3 and 5, offering new insights into the genetic diagnosis of Lennox-Gastaut syndrome, a severe form of developmental epileptic encephalopathy. Genetic Brea
- Revolutionizing Healthcare: The Dual Impact of Telemedicine and Methadone Programshttps://reachmd.com/news/revolutionizing-healthcare-the-dual-impact-of-telemedicine-and-methadone-programs/2471245/In recent years, particularly during the COVID-19 pandemic, telemedicine has emerged as a pivotal tool for maintaining healthcare delivery, while methadone programs have shown promising results in improving HIV care among formerly incarcerated individuals. This article expl
- FDA Approves New HA Gels From Evolushttps://reachmd.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com
- Unraveling Chromosomal Complexities: A New Genetic Diagnosis in Lennox-Gastaut Syndromehttps://reachmd.com/news/unraveling-chromosomal-complexities-a-new-genetic-diagnosis-in-lennox-gastaut-syndrome/2471154/A groundbreaking case study reveals the first-known chromothripsis involving chromosomes 3 and 5, offering new insights into the genetic diagnosis of Lennox-Gastaut syndrome, a severe form of developmental epileptic encephalopathy. Genetic Brea
- Study Shows Oral Minoxidil Improves Patient Outcomes for Hair Losshttps://reachmd.com/news/study-shows-oral-minoxidil-improves-patient-outcomes-for-hair-loss/2471041/New research in the Journal of Drugs in Dermatology shows oral minoxidil outperforming topical formulations in terms of patient adherence, satisfaction, and ease of use, without significantly increasing systemic side effects. Researchers on the study studied 50 patients using eith